Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Conmed (CNMD)
NYSE:CNMD
Holding CNMD?
Track your performance easily
CNMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$61.05 - $114.80
Previous Close$68.63
Volume1.40M
Average Volume (3M)425.12K
Market Cap
$2.16B
Enterprise Value$3.10B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$940.81M
Price to Earnings (P/E)16.6
Beta0.88
Next Earnings
Jan 30, 2025EPS Estimate
$1.21Last Dividend Ex-Date
Dec 20, 2024Dividend Yield1.14%
Share Statistics
EPS (TTM)4.22
Shares Outstanding30,890,853
10 Day Avg. Volume5,262,831
30 Day Avg. Volume425,122
Standard Deviation0.11
R-Squared0.47
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.27
Price to Sales (P/S)1.68
Price to Cash Flow (P/CF)10.60
P/FCF Ratio9.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.41
Enterprise Value/Gross Profit4.59
Enterprise Value/Ebitda11.32
Forecast
1Y Price Target
$82.17Price Target Upside19.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Conmed News
PremiumCompany Announcements
CONMED Corporation Reports Strong Q3 2024 Results
PremiumCompany Announcements
Conmed Announces New CEO Amid Strong Q3 Performance
Bulls Say, Bears Say
Bulls Say
Financial PerformanceManagement raised their EPS guidance and noted that US AirSeal sales remain strong with surgeons returning for more complex procedures.
Leadership TransitionThe transition to the new CEO is expected to be seamless as the incoming CEO, Patrick Beyer, has been with the company since 2014 and is already visible with investors.
Product PerformanceBioBrace is a bioinductive implant designed to enhance the quality and durability of tendon/ligament repair, with surgeons exploring its use in over 47 different indications.
Bears Say
Investor SentimentShort interest on the stock remains high at 8.5%, indicating investor skepticism.
Operational ChallengesCNMD does not anticipate being able to make up all regional procedure deferral impacts in Q4.
Revenue GuidanceManagement lowered their revenue guidance slightly.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CNMD FAQ
What was Conmed’s price range in the past 12 months?
Conmed lowest stock price was $61.05 and its highest was $114.80 in the past 12 months.
What is Conmed’s market cap?
Currently, no data Available
When is Conmed’s upcoming earnings report date?
Conmed’s upcoming earnings report date is Jan 30, 2025 which is in 40 days.
How were Conmed’s earnings last quarter?
Conmed released its earnings results on Oct 30, 2024. The company reported $1.05 earnings per share for the quarter, beating the consensus estimate of $1.023 by $0.027.
Is Conmed overvalued?
According to Wall Street analysts Conmed’s price is currently Undervalued.
Does Conmed pay dividends?
Conmed pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 1.14%. See more information on Conmed dividends here
What is Conmed’s EPS estimate?
Conmed’s EPS estimate is $1.21.
How many shares outstanding does Conmed have?
Conmed has 30,890,854 shares outstanding.
What happened to Conmed’s price movement after its last earnings report?
Conmed reported an EPS of $1.05 in its last earnings report, beating expectations of $1.023. Following the earnings report the stock price went up 4.564%.
Which hedge fund is a major shareholder of Conmed?
Among the largest hedge funds holding Conmed’s share is Deerfield Management Company, LP. It holds Conmed’s shares valued at 44M.
---
Conmed Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$82.17 (19.73% Upside)
$82.17 (19.73% Upside)
Blogger Sentiment
Bullish
CNMD Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 22.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.2%
Last 30 Days ▲ 2.4%
Last 30 Days ▲ 2.4%
Fundamentals
Return on Equity
15.24%
Trailing 12-Months
Asset Growth
-0.43%
Trailing 12-Months
Company Description
Conmed
CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its product lines also include orthopedic surgey and general surgery. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Utica, NY.
---
CNMD Company Deck
---
CNMD Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected positive developments in revenue and earnings growth, strong performance in the U.S. market, and successful leadership succession. However, challenges were noted with international sales, impacts from recent hurricanes, and IV fluid shortages affecting procedure scheduling.Read More>---
CNMD Stock 12 Month Forecast
Average Price Target
$82.17
▲(19.73% Upside)
Technical Analysis
Best Analysts Covering CNMD
1 Year
1 Year Success Rate
12/24 ratings generated profit
1 Year Average Return
+3.81%
reiterated a buy rating 2 months ago
Copying Rick Wise's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +3.81% per trade.
---